title: Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
authors: From Kings College Hospital London, UK.
authors: Timothy
authors: T
authors: Tully
authors: From Kings College Hospital London, UK.
authors: Alastair
authors: A
authors: Barkley
authors: From Kings College Hospital London, UK. eli.silber@nhs.net.
authors: Eli
authors: E
authors: Silber
mesh_terms: D000328:Adult; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007866:Leg; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use*; D012008:Recurrence; D012075:Remission, Spontaneous; D012514:Sarcoma, Kaposi / Q000139:chemically induced* / Q000175:diagnosis*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine